The Elecsys Anti-SARS-CoV-2 S targets antibodies, which are directed against the particular region of the viral spike protein responsible for binding to the host cell receptor, which is required for the virus to enter the host cell
Roche Diagnostics launches Elecsys Anti-SARS-CoV-2Â S test in India
Roche Diagnostics launches Elecsys Anti-SARS-CoV-2Â S test in India
22 January 2021 | News The Elecsys Anti-SARS-CoV-2Â S targets antibodies which are directed against the particular region of the viral spike protein
Source: diagnostics.roche.com
Roche Diagnostics India has announced the launch of its antibody test SARS-CoV-2 test-Elecsys Anti-SARS-CoV-2 S. The test is CE IVD approved and has received ICMR and CDSCO approval in India. It is an in vitro test, that quantifies antibodies against the receptor-binding domain (RBD) of spike (S) protein SARS-CoV-2 in human serum and plasma, and determines the body’s immune response to the virus.